Department of Pharmacology and Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, New York 14214, USA.
BMC Genomics. 2010 Oct 19;11:583. doi: 10.1186/1471-2164-11-583.
Two year cancer bioassays conducted by the National Toxicology Program have shown chronic exposure to dioxin-like compounds (DLCs) to lead to the development of both neoplastic and non-neoplastic lesions in the hepatic tissue of female Sprague Dawley rats. Most, if not all, of the hepatotoxic effects induced by DLC's are believed to involve the binding and activation of the transcription factor, the aryl hydrocarbon receptor (AhR). Toxicogenomics was implemented to identify genomic responses that may be contributing to the development of hepatotoxicity in rats.
Through comparative analysis of time-course microarray data, unique hepatic gene expression signatures were identified for the DLCs, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (100 ng/kg/day) and 3,3',4,4',5-pentachlorobiphenyl (PCB126) (1000 ng/kg/day) and the non-DLC 2,2',4,4',5,5',-hexachlorobiphenyl (PCB153) (1000 μg/kg/day). A common time independent signature of 41 AhR genomic biomarkers was identified which exhibited at least a 2-fold change in expression following subchronic (13-wk) and chronic (52-wk) p.o. exposure to TCDD and PCB126, but not the non DLC, PCB153. Real time qPCR analysis validated that 30 of these genes also exhibited at least a 2-fold change in hepatic expression at 24 hr following a single exposure to TCDD (5 μg/kg, po). Phenotypic anchoring was conducted which identified forty-six genes that were differently expressed both following chronic p.o. exposure to DLCs and in previously reported studies of cholangiocarcinoma or hepatocellular adenoma.
Together these analyses provide a comprehensive description of the genomic responses which occur in rat hepatic tissue with exposure to AhR ligands and will help to isolate those genomic responses which are contributing to the hepatotoxicity observed with exposure to DLCs. In addition, the time independent gene expression signature of the AhR ligands may assist in identifying other agents with the potential to elicit dioxin-like hepatotoxic responses.
国家毒理学计划进行的为期两年的癌症生物测定表明,慢性接触二恶英类化合物(DLCs)会导致雌性 Sprague Dawley 大鼠肝组织中出现肿瘤和非肿瘤病变。大多数(如果不是全部)DLC 诱导的肝毒性作用被认为涉及转录因子芳香烃受体(AhR)的结合和激活。毒理基因组学被用于鉴定可能导致大鼠肝毒性发展的基因组反应。
通过对时间过程微阵列数据的比较分析,确定了 DLCs(2,3,7,8-四氯二苯并-p-二恶英(TCDD)(100ng/kg/天)和 3,3',4,4',5-五氯联苯(PCB126)(1000ng/kg/天)以及非 DLC 2,2',4,4',5,5'-六氯联苯(PCB153)(1000μg/kg/天)的独特肝基因表达特征。鉴定出一个共同的时间独立的 41 个 AhR 基因组生物标志物的特征,这些标志物在亚慢性(13 周)和慢性(52 周)口服暴露于 TCDD 和 PCB126 后,其表达至少增加了 2 倍,但非 DLC PCB153 则没有。实时 qPCR 分析验证了这些基因中有 30 个在单次口服暴露于 TCDD(5μg/kg,po)后 24 小时肝表达也至少增加了 2 倍。进行了表型锚定,确定了 46 个在慢性口服暴露于 DLCs 后以及在先前报道的胆管癌或肝细胞腺瘤研究中表达不同的基因。
这些分析共同提供了一个全面的描述,即在大鼠肝组织中,AhR 配体暴露后会发生基因组反应,并将有助于分离出那些导致 DLC 暴露后观察到肝毒性的基因组反应。此外,AhR 配体的时间独立基因表达特征可能有助于识别其他具有引发二恶英样肝毒性反应潜力的物质。